Apollomics files Form 3 as director Yen Hung Hsien reports beneficial ownershipPUBT·37 minutes agoAPLMW+1.60%APLM-3.45%
Apollomics appoints Hung-Hsien Yen to board after two directors resignPUBT·Jul 21 at 02:13 PMAPLM-3.45%APLMW+1.60%
Strategic Spinoffs and Bold Overhauls Across 10 Under-the-Radar StocksGlobal Report·Jul 18 at 04:12 AMAWK+0.19%HLIT-3.53%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Jul 17 at 12:05 PMAPLM-3.45%APLMW+1.60%
Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watchrttnews·Jul 16 at 09:58 PMAPLM-3.45%ATAI+0.14%
U.S. stock market mid-session update: Apollomics rises 12.04%, boosting confidence in meeting Nasdaq listing requirementsPrice Alert·Jul 16 at 10:47 AMAPLM-3.45%
Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Datarttnews·Jul 15 at 10:42 PMIOVA-2.73%MANE-5.48%
Apollomics regains Nasdaq compliance with $35 million market value requirementPUBT·Jul 13 at 07:06 AMAPLM-3.45%APLMW+1.60%
Apollomics initiates dispute process with Launxp over unpaid $3.8 million vebreltinib license feePUBT·Jun 24 at 04:14 PMAPLMW+1.60%APLM-3.45%
Apollomics gets Nasdaq notice for falling below $35 million market value minimumPUBT·Jun 24 at 03:15 PMAPLM-3.45%APLMW+1.60%
Top Biotech Gainers: TNON Files S-1, NVCT Inks License Deal, FTH On Watch, RGNX To Resubmit BLArttnews·Jun 22 at 10:15 PMAZTR-0.55%FTH+1.91%
